SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Frontline Ltd. (FRO) trades at a trailing P/E of 21.6, forward P/E of 5.9. Trailing earnings yield is 4.64%, forward earnings yield 16.84%. PEG 0.02 (Peter Lynch undervalued ≤1.0). Graham Number is $20.79.
Criteria proven by this page:
- VALUE (77/100, Pass) — P/E is below market average (21.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.02); analyst target implies upside (+12.7%); earnings yield beats bond yields (4.64%).
- Forward P/E 5.9 (down from trailing 21.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 4.64% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 16.84% as earnings recover.
- Analyst consensus target $38.50 (+12.7% upside) — modest upside expected.
Overall SharesGrow Score: 61/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
77/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — FRO
Valuation Multiples
P/E (TTM)21.6
Forward P/E5.9
PEG Ratio0.02
Forward PEG0.02
P/B Ratio3.26
P/S Ratio4.16
EV/EBITDA11.6
Per Share Data
EPS (TTM)$1.70
Forward EPS (Est.)$5.75
Book Value / Share$11.28
Revenue / Share$8.83
FCF / Share$3.01
Yields & Fair Value
Earnings Yield4.64%
Forward Earnings Yield16.84%
Dividend Yield4.79%
Graham Number$20.79
SharesGrow IV$16.48 (-51.8%)
Analyst Target$38.50 (+12.7%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
9.5 |
-0.23 |
0.74 |
1.48 |
14.74% |
| 2017 |
-3.0 |
0.01 |
0.67 |
1.23 |
6.47% |
| 2018 |
-105.7 |
1.09 |
0.81 |
1.27 |
0.04% |
| 2019 |
15.9 |
-0.01 |
1.48 |
2.33 |
0.88% |
| 2020 |
2.9 |
0.02 |
0.75 |
1.00 |
25.67% |
| 2021 |
-94.0 |
0.92 |
0.85 |
1.88 |
- |
| 2022 |
5.5 |
0.00 |
1.15 |
1.82 |
1.29% |
| 2023 |
6.8 |
0.21 |
1.96 |
2.48 |
14.31% |
| 2024 |
6.4 |
-0.26 |
1.35 |
1.54 |
13.74% |
| 2025 |
12.8 |
-0.54 |
1.93 |
2.47 |
4.26% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.75 |
$754.31M |
$117.01M |
15.5% |
| 2017 |
$-1.56 |
$646.33M |
$-264.86M |
-41% |
| 2018 |
$-0.05 |
$742.27M |
$-8.4M |
-1.1% |
| 2019 |
$0.78 |
$957.32M |
$139.97M |
14.6% |
| 2020 |
$2.09 |
$1.22B |
$412.88M |
33.8% |
| 2021 |
$-0.06 |
$749.38M |
$-11.15M |
-1.5% |
| 2022 |
$2.22 |
$1.43B |
$475.54M |
33.2% |
| 2023 |
$2.95 |
$1.79B |
$656.41M |
36.7% |
| 2024 |
$2.23 |
$2.05B |
$495.58M |
24.2% |
| 2025 |
$1.70 |
$1.97B |
$379.08M |
19.3% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$5.83 |
$4.86 – $7.38 |
$1.93B |
$1.68B – $2.33B |
2 |
| 2027 |
$3.03 |
$1.93 – $4.40 |
$1.43B |
$1.18B – $1.67B |
4 |
| 2028 |
$2.71 |
$2.26 – $3.43 |
$1.39B |
$1.21B – $1.67B |
1 |
| 2029 |
$3.57 |
$2.97 – $4.52 |
$1.96B |
$1.71B – $2.36B |
1 |
